ICONIC-CD Protocol 77242113CRD3001: A Phase 2b/3 Randomized Double-blind Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Go Back to All Clinical Trials

ICONIC-CD Protocol 77242113CRD3001: A Phase 2b/3 Randomized Double-blind Placebo-Controlled Parallel Group Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Brief description of study

The purpose of this research study is to help researchers understand more about the possible effectiveness and safety of icotrokinra in patients with moderately to severely active Crohn’s disease.

Clinical Study Identifier: s25-00963

ClinicalTrials.gov Identifier: NCT07196722

Principal Investigator: Jordan E Axelrad.

Other Investigators: Elie S Al Kazzi, Shannon Chang, Adam Faye, Ariela Holmer, Lindsay Clarke, David P Hudesman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies